Even though 95% of RTT patients with the classical RTT phenotype have a pathogenic MECP2 mutation, some individuals with pathogenic MECP2 mutations lack the clinical characteristics of RTT [19]. The gene discussed is MECP2; the disease is Rett syndrome.